About Us

BOL is a pioneer in the botanical cannabinoid therapeutics market since 2008. Vertically integrated cannabinoid therapeutics operations cover the entire spectrum from cultivation to finished products in strict compliance with global GAP and GMP regulatory standards, with 2 main arms – Production & Pharmaceutical development.

Production

Production of botanical-based Active Pharmaceutical Ingredients (APIs) serving the markets for medical therapies, food supplements and cosmetics

icon_pharmaceutical

Pharmaceutical Development

Robust drug pipeline with 32 Phase 2 clinical trials on their way, representing one of the most comprehensive cannabinoid clinical trial portfolios in the industry.

Breath of Life Pharma (BOL), is one of the world's largest medical Cannabis production, research, and development facility and clinical trials hub

%

Market share in pharmacies in Israel under the new distribution regulation

Square feet of GACP cultivation facilites

Square feet of GMP production plant, labs, and office space

BOL ADVANTAGES

$

Low-cost structure production capabilities due to favorable climate conditions, regulation, low energy footprint and labor cost which leads to cost leadership in North America and Europe.

$

Producing a range of 99% pure cannabinoids: THC, CBD as well as CBN, CBG and CBC to supply commercial, clinical, and research entities.

$

Positioned as a world market leader in cannabinoid pharmaceutical drug development: Comprehensive  cannabinoid clinical trial portfolio of 32 phase 2 trials.

$

Unique patentable formulations paired with innovative drug delivery systems: Targeting specific indications enhances bioavailability, providing greater efficacy while reducing side effects.

$

PK studies in progress to launch new drug delivery platforms: Sublingual tablets, metered dose inhalers, dry powder inhalers and gel capsules.

$

Commercial production capacity of GMP pharma cannabinoid APIs: Enabling a breakthrough in the bottleneck of clinical trials held up by highly limited availability of API production capacity.

FOCUS AREAS

;

Cannabinoid Extracts and APIs – Cannabinoid based extracts and APIs for the pharmaceuticals, food supplements, and cosmetics industries

;

Discover other cannabinoids and formulations combined with innovative pharmaceutical delivery solutions by engaging in R&D.

;

Cannabinoid Based Products РContract manufacturing of private label and  branded finished product for the pharmaceuticals, cosmetics, and food supplements industries

;

Breath of Life Pharma (BOL), is one of the world’s largest medical Cannabis production, research, and development facility and clinical trials hub

;

Medical Cannabis for the Global Markets.

;

Develop unmet medical needs and orphan drug candidates up to successful completion of phase 2 clinical trials and license IP to leading companies.

Font Resize
Contrast